EDGAR Filing Documents for 0001171520-22-000449

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0001171520-22-000449

Filing Date

2022-08-03

Accepted

2022-08-03 16:17:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		eps10403_jds.htm	SC 13D/A	187717
2	TERMINATION OF JOINT FILING AND SOLICITATION AGREEMENT	ex99-1.htm	EX-99	7923
3	JOINT FILING AGREEMENT	ex99-2.htm	EX-99	5662
	Complete submission text file	0001171520-22-000449.txt		202630

Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080

Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761

CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 221132862
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024

Business Address

SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: SC 13D/A